NASDAQ:LYEL | Key Financial Ratios | Lyell Immunopharma, Inc.

Complete source-backed ratio history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-305.36-79.86%-106.27%
2026-03-317.23-70.28%-90.04%
2025-12-315.28-80.71%-110.57%
2025-09-3010.3-79.83%-98.95%
2025-06-307.65-85.98%-110.86%
2025-03-317.49-77.83%-99.41%
2024-12-317.06-69.88%-89.60%
2024-09-3013.43-32.94%-38.44%
2024-06-3016.19-32.14%-37.12%
2024-03-3116.51-32.89%-37.86%
2023-12-3116.07-31.28%-35.82%
2023-09-3016.74-23.91%-27.25%
2023-06-3017.63-25.08%-28.43%
2023-03-3120.27-20.66%-23.21%
2022-12-3117.59-19.53%-21.98%
2022-09-3012.88-26.44%-31.51%
2022-06-3013.26-23.20%-27.31%
2022-03-3115.24-24.56%-29.88%
2021-12-3113.4-22.19%-26.91%
2021-09-3010.65-17.14%-20.82%
2021-06-3013.11-15.63%-18.81%
2021-03-3168.93%
2020-12-3112.53

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-315.28-80.71%-110.57%
2024-12-317.06-69.88%-89.60%
2023-12-3116.07-31.28%-35.82%
2022-12-3117.59-19.53%-21.98%
2021-12-3113.4-22.19%-26.91%
2020-12-3112.53-22.51%69.90%
2019-12-31116.44%